Cefuroxime
(Ceftin (po), Kefurox, Zinacef) |
Category:
Antibiotic
Description:
Cephalosporin,
Second Generation
Indications:
-
Oral tablets/suspension:
-
pharyngitis/tonsillitis (S.
pyogenes)
-
otitis media (S.
pneumoniae, H. influenzae, M. catarrhalis, S. pyogenes)
-
acute bacterial maxillary sinusitis (S.
pneumoniae, H. influenzae)
-
acute bacterial exacerbation of chronic
bronchitis, secondary infections due to acute bronchitis (S.
pneumoniae, H. influenzae, H. parainfluenzae)
-
urinary tract infections (E.
coli, K. pneumoniae)
-
skin infections (S.
aureus, S. pyogenes)
-
uncomplicated gonorrhea (N.
gonorrhoeae)
-
early Lyme disease (Borrelia
burgdorferi)
-
Parenteral
-
lower respiratory tract (S.
pneumoniae, H.
influenzae, Klebsiella species, S.
aureus, S. pyogenes, E. coli)
-
urinary tract infections (E. coli, K. pneumoniae)
-
septicemia (S.
pneumoniae, H. influenzae, Klebsiella species, S. aureus, S. pyogenes, E. coli)
-
meningitis (N.
meningitidis)
-
gonorrhea (N.
gonorrhoeae)
-
skin, bone and joint infections (S.
aureus, S. pyogenes, Enterobacter species, Klebsiella species, E. coli)
Contraindications:
Precautions:
-
Pregnancy
category B
-
Use
with caution in patients with penicillin allergy (5-10% chance of
cross-reactivity)
-
Dosage
modifications are generally only required in patients with severe
renal impairment
-
Counsel
patient to finish all medication to prevent development of resistance
-
Do
not crush tablets, swallow whole or use suspension dosing
-
NOTE:
oral tablets and suspension are NOT bioequivalent
Adverse
Reactions (Side Effects):
-
Hypersensitivity
reactions
-
Gastrointestinal:
nausea, vomiting, diarrhea
-
Vaginitis
|
Dosage:
-
Administered
orally (tablets and suspension) and by injection (IV or IM)
-
Pharyngitis/tonsillitis:
-
Otitis media:
-
Impetigo:
-
Acute bacterial exacerbation of chronic
bronchitis/secondary infections of to acute bronchitis:
-
Urinary tract infections:
-
Uncomplicated skin infections:
-
Uncomplicated gonorrhea infections:
-
Disseminated gonococcal:
-
Early Lyme disease:
-
Uncomplicated pneumonia:
-
Severe or complicated infections and bone or
joint infections:
-
Life-threatening
infections:
-
Bacterial
meningitis:
|
|
|
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|